News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Corbus to host Sept 14 call to disclose topline CANYON-1 data for CRB-913 in obesity.
  • Cellectis will hold a Sept 14 webcast to provide a business update on its allogeneic CAR-T and gene therapy programs.
  • CEA Industries reported Q1 net loss of $11.4 million, driven by a $15.3 million unrealized loss on BNB tokens.
  • Biodexa posted a £1.84 million loss for H1 and flagged material uncertainty around future financing.
  • Impact BioMedical announced a 1-for-12.62 reverse split effective Sept 23 ahead of a planned merger with Zoar Ltd.
  • Star Bulk priced a €24.50 share offering with demand over six times allotment, indicating strong investor interest.

Latest Articles

Ralph Lauren Tops Q1 Estimates as Affluent Shoppers Propel Luxury Lines

Ralph Lauren Tops Q1 Estimates as Affluent Shoppers Propel Luxury Lines

Ralph Lauren reported first-quarter results that exceeded Wall Street expectations, supported by demand for its premium collections from younger and affluent consumers in Asia and North America. The company raised its full-year revenue growth forecast to a 5% to 6% range, though the midpoint remains below analysts' estimates. Quarterly revenue and …

Fox Posts Q4 EPS Beat as World Cup Drives Advertising Surge

Fox Posts Q4 EPS Beat as World Cup Drives Advertising Surge

Fox Corporation reported fourth-quarter earnings per share of $1.79, topping the $1.41 analyst estimate by $0.38, while revenue reached $4.21 billion versus the $3.62 billion consensus. The company attributed a large portion of the revenue upside to advertising tied to its FIFA Men's World Cup broadcasts, along with digital gains at Tubi and height…

High-grade explosives found on drone near Leipzig/Halle; Ukrainian cargo plane reported carrying ammunition

High-grade explosives found on drone near Leipzig/Halle; Ukrainian cargo plane reported carrying ammunition

Media outlets report that a Ukrainian cargo airplane parked near a drone discovered at Leipzig/Halle airport was transporting military ammunition. Forensic investigators found the explosives affixed to the drone were of a high military grade, a development that has broadened a counterterrorism investigation into incidents that disrupted operations …

DoorDash Pops After Better-Than-Expected Q2; Guidance, Subscriptions, and a Favorable Court Ruling Drive Move

DoorDash Pops After Better-Than-Expected Q2; Guidance, Subscriptions, and a Favorable Court Ruling Drive Move

DoorDash shares climbed 5.2% in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst forecasts on most key measures. Revenue of $4.45 billion and adjusted EBITDA of $914 million topped estimates, while management pointed to strong restaurant operations, improving unit economics in new verticals, and record…

Avient Shares Rise After Q2 Beat, Guidance Lift and Margin Expansion

Avient Shares Rise After Q2 Beat, Guidance Lift and Margin Expansion

Avient Corp surged in pre-market trading after reporting second-quarter 2026 results that exceeded analyst expectations on earnings and revenue, alongside wider adjusted EBITDA margins and a raised full-year adjusted EPS outlook. Organic sales growth and a modest foreign exchange tailwind supported top-line expansion, while the company used strong …

Bentley Systems Shares Fall in Pre-Market After Revenue Shortfall in Q2 2026

Bentley Systems Shares Fall in Pre-Market After Revenue Shortfall in Q2 2026

Bentley Systems Inc. fell about 2.9% in pre-market trading after releasing second-quarter 2026 results that showed adjusted earnings per share above analyst estimates but total revenue slightly below consensus. Investors reacted negatively to the revenue miss and a sequential revenue drop from the prior quarter, even as subscription revenue continu…

Poll: Egypt's annual inflation likely climbed to 15.6% in July

Poll: Egypt's annual inflation likely climbed to 15.6% in July

A Reuters poll of 13 analysts shows Egypt's annual headline inflation is expected to have risen to 15.6% in July from 14.3% in June, driven by an unfavourable base effect and stronger food and non-food price pressures. Core inflation is also projected to remain elevated. The statistics agency CAPMAS will publish the official July reading on August …

Core AI Holdings Reports Strong Operational Execution Across AI Products, Data Intelligence and Growth Initiatives

Core AI Holdings Reports Strong Operational Execution Across AI Products, Data Intelligence and Growth Initiatives

Core AI Holdings, a Nasdaq-listed global AI technology firm, announced strong operational execution in the first half of 2026, achieving accelerated product milestones ahead of schedule and significant growth in user acquisition across its gaming portfolio. The company expanded its AI-driven analytics capabilities, improved internal reporting accur…

VivoSim Provides Financial and Listing Compliance Update

VivoSim Provides Financial and Listing Compliance Update

VivoSim Labs, a Nasdaq-listed biopharma services provider specializing in 3D human tissue models, announced regaining compliance with Nasdaq Listing Rule 5550(b)(1) following a $5 million milestone payment from Eli Lilly, additional escrow funds, and a $4 million equity financing. With cash on hand exceeding $10 million and a significant increase i…

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Pacira BioSciences announced positive two-year Phase 1 clinical trial results for PCRX-201, its investigational gene therapy for moderate-to-severe knee osteoarthritis. The therapy showed a strong safety profile and sustained improvements in pain, stiffness, and function following a single intra-articular injection. With these encouraging results, …

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

Annexon, Inc. reported early positive clinical responses from the initial cohort of U.S. and European Guillain-Barré syndrome (GBS) patients treated with tanruprubart in its ongoing FORWARD study. All ten patients demonstrated rapid and meaningful improvement in strength and functionality within days, reinforcing earlier Phase 3 trial results and s…

ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa

ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa

ASP Isotopes Inc. announced that its subsidiary Renergen's subsidiary, Tetra4, has entered a five-year take-or-pay contract to supply liquified natural gas (LNG) to a South African food processor. This contract supports Phase 1 of the Virginia Gas Project, targeting commercial production in Q3 2026, with approximately 75% of Phase 1 LNG volumes now…

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Praxis Precision Medicines announced positive mid-cycle FDA meetings for its drug candidates ulixacaltamide and relutrigine, with no major safety or efficacy concerns and no advisory committee meetings planned. The company is accelerating commercial preparations for potential approvals in essential tremor and developmental epileptic encephalopathie…

Globalstar Announces Second Quarter 2026 Financial Results

Globalstar Announces Second Quarter 2026 Financial Results

Globalstar, Inc. reported its second quarter 2026 financial results, generating $64.8 million in revenue with record high Commercial IoT subscriber activations. The company continues regulatory progress on its merger agreement with Amazon and is advancing next-generation satellite constellation initiatives. Despite revenue growth in some segments, …

Freshworks to Participate in Oppenheimer 29th Annual Technology, Internet & Communications Conference

Freshworks to Participate in Oppenheimer 29th Annual Technology, Internet & Communications Conference

Freshworks Inc. announced that COO and CFO Tyler Sloat will participate in a fireside chat at the Oppenheimer 29th Annual Technology, Internet & Communications Conference. The session is set for August 12, 2026, with an audio replay available on Freshworks' investor relations site. The company is positioned as an AI-powered unified service operatio…

Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nano-X Imaging Ltd., a Nasdaq-listed medical imaging technology company, has priced an $8 million registered direct offering with a single long-term institutional investor. The offering consists of 8 million ordinary shares and warrants exercisable at $1.15 per share. Proceeds will be used for working capital and general corporate purposes. The com…

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

MIRA Pharmaceuticals announced positive toxicokinetic data from a 7-day repeated-dose study of their obesity treatment candidate SKNY-1 in Beagle dogs. The drug showed dose-dependent systemic exposure and rapid absorption, de-risking dose selection and supporting advancement into GLP toxicology studies and IND-enabling development. SKNY-1 aims to t…